CRISPR screening by AAV episome-sequencing (CrAAVe-seq) is a highly scalable cell type-specific <i>in vivo</i> screening platform
Biswarathan Ramani(University of California, San Francisco), Martin Kampmann(University of California, San Francisco)
Cited by 10
Related Papers
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
|Nature Neuroscience|2022|248
Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes
|Human Molecular Genetics|2017|55
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
|bioRxiv (Cold Spring Harbor Laboratory)|2020|40
A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease states
|bioRxiv (Cold Spring Harbor Laboratory)|2021|19